» Articles » PMID: 31807986

The QR-max Index, a Novel Electrocardiographic Index for the Determination of Left Ventricular Conduction Delay and Selection of Cardiac Resynchronization in Patients with Non-left Bundle Branch Block

Abstract

Non-left bundle branch block (non-LBBB) remains an uncertain indication for cardiac resynchronization therapy (CRT). Non-LBBB includes right bundle branch block (RBBB) and non-specific LV conduction delay (NSCD), two different electrocardiogram (ECG) patterns which are not generally considered to be associated with LV conduction delay as judged by the invasive assessment of the Q-LV interval. We evaluated whether a novel ECG interval (QR-max index) correlated with the degree of LV conduction delay regardless of the type of non-LBBB ECG pattern, and could, therefore, predict CRT response. In 173 non-LBBB patients on CRT (92 NSCD, 81 RBBB), the QR-max index was measured as the maximum interval from QRS onset to R-wave offset in the limb leads. The correlation between QR-max index and Q-LV interval and the impact of the QR-max index on time to first heart failure hospitalization during 3-year follow-up were assessed. Q-LV correlated better with the QR-max index than with QRSd, particularly in the RBBB group (r = 0.91; p < 0.001 vs. r = 0.19; p < 0.089), while the correlations were r = 0.79 (p < 0.01) and r = 0.68 (p < 0.01), respectively, in the NSCD group. In both groups, the QR-max index was significantly more able than QRSd to identify CRT responders (AUC 0.825 vs. 0.576; p = 0.0008 in RBBB; AUC 0.738 vs. 0.701; p = 0.459 in NSCD). A QR-max index exceeding a cutoff value of 120 ms was associated with CRT response, with predictive values of 86.8 and 81.4% in RBBB and NSCD, respectively. The QR-max index reflects the degree of LV electrical delay regardless of QRS duration in RBBB and NSCD patients and is a useful indicator of suitability for CRT in non-LBBB patients.

Citing Articles

New Pacing Techniques and Non-Invasive Methods That May Improve Response to Cardiac Resynchronization Therapy.

Vereckei A J Cardiovasc Dev Dis. 2024; 11(7).

PMID: 39057628 PMC: 11277212. DOI: 10.3390/jcdd11070208.


Useful Electrocardiographic Signs to Support the Prediction of Favorable Response to Cardiac Resynchronization Therapy.

Simon A, Pilecky D, Kiss L, Vamos M J Cardiovasc Dev Dis. 2023; 10(10).

PMID: 37887872 PMC: 10607456. DOI: 10.3390/jcdd10100425.


2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.

Chung M, Patton K, Lau C, Dal Forno A, Al-Khatib S, Arora V J Arrhythm. 2023; 39(5):681-756.

PMID: 37799799 PMC: 10549836. DOI: 10.1002/joa3.12872.


2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.

Chung M, Patton K, Lau C, Dal Forno A, Al-Khatib S, Arora V Heart Rhythm. 2023; 20(9):e17-e91.

PMID: 37283271 PMC: 11062890. DOI: 10.1016/j.hrthm.2023.03.1538.


Novel electrocardiographic dyssynchrony criteria that may improve patient selection for cardiac resynchronization therapy.

Katona G, Vereckei A J Geriatr Cardiol. 2022; 19(1):31-43.

PMID: 35233221 PMC: 8832041. DOI: 10.11909/j.issn.1671-5411.2022.01.006.